Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS)

Huber, Markus; Ledergerber, Bruno; Jaccard, René; Elzi, Luigia; Furrer, Hansjakob; Hirschel, Bernard; Cavassini, Matthias; Bernasconi, Enos; Schmid, Patrick; Weber, Rainer

doi:10.1186/1758-2652-13-s4-p231

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since 1992, the World Health Organization (WHO)'s International Classification of Diseases has classified nicotine dependence as a mental and behavioural disorder . As nicotine dependence is an addiction, it is difficult for the smoker to control it without adequate support, and the expected success rate without anti‐smoking therapy is low (3–8%) in both the general population and the HIV‐infected community . Although a series of drug therapies targeting nicotine dependence have been the subject of continuing investigation since the mid‐20th Century, there is still significant reluctance among the general population and the HIV‐positive community to accept these therapies.…”

Section: Scientific Evidence In Favour Of Smoking Cessation Strategiementioning

confidence: 99%

How to address smoking cessation in HIV patients

Calvo-Sánchez

Martínez

2014

HIV Medicine

View full text Add to dashboard Cite

Tobacco consumption is the modifiable risk factor contributing most to the development of non-AIDS-defining events among persons living with HIV/AIDS (PLWHA). Clinicians' awareness of this problem is critical and not yet adequate. Practical information issued by public health authorities or contained in experts' clinical guidelines regarding how to address smoking cessation in PLWHA is scarce. The aim of this review is to provide physicians with comprehensive and practical information regarding how to identify HIV-positive patients willing to stop smoking and those more likely to succeed, how to choose the most suitable strategy for an individual patient, and how to help the patient during the process. In the light of current evidence on the efficacy and benefits of stopping smoking in PLWHA, physicians must actively pursue smoking cessation as a major objective in the clinical care of PLWHA.

show abstract

Section: Scientific Evidence In Favour Of Smoking Cessation Strategiementioning

confidence: 99%

How to address smoking cessation in HIV patients

Calvo-Sánchez

Martínez

2014

HIV Medicine

View full text Add to dashboard Cite

show abstract

“…However, lifestyle factors such as alcohol consumption, smoking and recreational drug use may have an impact on adherence to ART and HIV outcomes as well as increasing risk of non‐HIV‐related morbidity. Previous questionnaire studies have suggested that alcohol, smoking and recreational drug use are prevalent in PLWH [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ].…”

Section: Introductionmentioning

confidence: 99%

Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses

et al. 2021

View full text Add to dashboard Cite

Objectives: There is increasing evidence to suggest that people living with HIV (PLWH) have significant morbidity from alcohol, recreational drug use and cigarette smoking. Our aim was to report associations of these factors with antiretroviral therapy (ART) non-adherence, viral non-suppression and subsequent viral rebound in PLWH. Methods: The Antiretroviral Sexual Transmission Risk and Attitudes (ASTRA) study recruited PLWH attending eight outpatient clinics in England between February 2011 and December 2012. Data included self-reported excessive drinking (estimated consumption of > 20 units of alcohol/week), alcohol dependency (CAGE score ≥ 2 with current alcohol consumption), recreational drug use (including injection drug use in the past 3 months), and smoking status. Among participants established on ART, cross-sectional associations with ART non-adherence [missing ≥2 consecutive days of ART on ≥2 occasions in the past three months] and viral-non suppression [viral load (VL) > 50 copies/mL] were assessed using logistic regression. In participants from one centre, longitudinal associations with subsequent viral rebound (first VL > 200 copies/mL) in those on ART with VL ≤ 50 copies/mL at baseline were assessed using Cox regression during a 7-year follow-up.Results: Among 3258 PLWH, 2248 (69.0%) were men who have sex with men, 373 (11.4%) were heterosexual men, and 637 (19.6%) were women. A CAGE score ≥ 2 was found in 568 (17.6%) participants, 325 (10.1%) drank > 20 units/week, 1011 (31.5%) currently smoked, 1242 (38.1%) used recreational drugs and 74(2.3%) reported injection drug use. In each case, prevalence was much more common among men than among women. Among 2459 people on ART who started at least 6 months previously, a CAGE score ≥ 2, drinking > 20 units per week, current smoking, injection and non-injection drug use were all associated withThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract